AU2001263281A1 - Polyethylene glycol (peg) polymers for the promotion of angiogenesis - Google Patents

Polyethylene glycol (peg) polymers for the promotion of angiogenesis

Info

Publication number
AU2001263281A1
AU2001263281A1 AU2001263281A AU6328101A AU2001263281A1 AU 2001263281 A1 AU2001263281 A1 AU 2001263281A1 AU 2001263281 A AU2001263281 A AU 2001263281A AU 6328101 A AU6328101 A AU 6328101A AU 2001263281 A1 AU2001263281 A1 AU 2001263281A1
Authority
AU
Australia
Prior art keywords
angiogenesis
peg
promotion
polymers
polyethylene glycol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001263281A
Inventor
Philippe Leboulch
Robert Pawliuk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bluebird Bio Inc
Original Assignee
Genetix Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetix Pharmaceuticals Inc filed Critical Genetix Pharmaceuticals Inc
Publication of AU2001263281A1 publication Critical patent/AU2001263281A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02—Polyalkylene oxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00—Applications
    • C08L2203/02—Applications for biomedical use

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001263281A 2000-05-18 2001-05-18 Polyethylene glycol (peg) polymers for the promotion of angiogenesis Abandoned AU2001263281A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US20534600P 2000-05-18 2000-05-18
US60205346 2000-05-18
US21132300P 2000-06-14 2000-06-14
US60211323 2000-06-14
PCT/US2001/016175 WO2001087312A1 (en) 2000-05-18 2001-05-18 Polyethylene glycol (peg) polymers for the promotion of angiogenesis

Publications (1)

Publication Number Publication Date
AU2001263281A1 true AU2001263281A1 (en) 2001-11-26

Family

ID=26900347

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001263281A Abandoned AU2001263281A1 (en) 2000-05-18 2001-05-18 Polyethylene glycol (peg) polymers for the promotion of angiogenesis

Country Status (3)

Country Link
US (1) US20020013261A1 (en)
AU (1) AU2001263281A1 (en)
WO (1) WO2001087312A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ518077A (en) * 2000-08-04 2003-11-28 Human Genome Sciences Inc Biologically active fragments, analogues and derivatives of VEGF-2 for the treatment of peripheral artery diseases such as critical limb ischemia and coronary disease
WO2002083704A1 (en) * 2001-04-13 2002-10-24 Human Genome Sciences, Inc. Vascular endothelial growth factor 2
US20050232921A1 (en) * 2001-04-13 2005-10-20 Rosen Craig A Vascular endothelial growth factor 2
WO2002083849A2 (en) * 2001-04-13 2002-10-24 Human Genome Sciences, Inc. Vascular endothelial growth factor 2
US20120141424A1 (en) * 2009-01-07 2012-06-07 Vegenics Pty Limited Materials and Methods for the Treatment of Hypertension
US8470892B2 (en) * 2010-08-10 2013-06-25 Puran S. Bora Method of inducing neovascularization

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5529914A (en) * 1990-10-15 1996-06-25 The Board Of Regents The Univeristy Of Texas System Gels for encapsulation of biological materials
ATE363292T1 (en) * 1998-09-04 2007-06-15 Scios Inc HYDROGEL COMPOSITIONS WITH CONTROLLED RELEASE OF GROWTH FACTORS
WO2001015738A2 (en) * 1999-09-02 2001-03-08 Rice University Nitric oxide-producing hydrogel materials
AU1072801A (en) * 1999-10-01 2001-05-10 Essentia Biosystems, Inc. Gel-forming compositions

Also Published As

Publication number Publication date
WO2001087312A1 (en) 2001-11-22
US20020013261A1 (en) 2002-01-31

Similar Documents

Publication Publication Date Title
AU2002215384A1 (en) Hydroxyapatite-targeting poly(ethylene glycol) and related polymers
HK1054684A1 (en) Multivalent platform molecules comprising high molecular weight polyethylene oxide
AU2001253151A1 (en) Wheeled platforms
MXPA03007650A (en) Sophthalic acid glycol ester solution.
AU2002248232A1 (en) Spiral couplers
AU2002228702A1 (en) Entertainment platform
AU6230501A (en) Propylene polymers and process for the preparation thereof
WO2002038718A3 (en) Solvent compositions
AU2002351624A1 (en) Tripartite molecular beacons
AU2001286657A1 (en) Propylene polymer composition
WO2002072010A3 (en) Taxane prodrugs
AU2002218410A1 (en) Retractable towers
AU1965501A (en) Compact molecular drag vacuum pump
AU2002219717A1 (en) High molecular weight oxidised cellulose
AU2002357806A1 (en) Novel monofunctional polyethylene glycol aldehydes
AU2765401A (en) Vial coupler
AU2001263281A1 (en) Polyethylene glycol (peg) polymers for the promotion of angiogenesis
AU2001285122A1 (en) Low molecular weight polyhydroxyalkanoate molding compositions
AU2001255754A1 (en) Methods and compositions for the manufacture of molecular beacons
AUPQ901700A0 (en) Molecular markers
AU7059000A (en) Multimodal structured hardcoatings made from micro-nanocomposite materials
AU5166700A (en) C-cam as an angiogenesis inhibitor
AU2001255129A1 (en) Molecular markers
AU2001282541A1 (en) Medicinal compositions
AU2002214648A1 (en) High capacitance drive fast slewing amplifier